Weight-loss giant Novo Nordisk's shares rose over 5% on Friday to a high last touched in October, driven by "encouraging" early U.S. prescription data for its Wegovy pill, which the firm hopes will ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果